Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.55 USD | +0.66% | +2.19% | -0.44% |
Mar. 05 | Top Premarket Gainers | MT |
Feb. 09 | Edesa Biotech, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 14.63M |
---|---|---|---|---|---|
Net income 2024 * | -8M | Net income 2025 * | -10M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.96
x | P/E ratio 2025 * |
-2.73
x | Employees | 16 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.55% |
1 day | +0.66% | ||
1 week | +2.19% | ||
Current month | +2.41% | ||
1 month | -2.15% | ||
3 months | -2.57% | ||
6 months | +45.37% | ||
Current year | -0.44% |
Managers | Title | Age | Since |
---|---|---|---|
Pardeep Nijhawan
FOU | Founder | 53 | 07-06-11 |
Michael Brooks
PSD | President | 46 | 15-08-31 |
Stephen Lemieux
DFI | Director of Finance/CFO | 48 | 23-07-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sean MacDonald
BRD | Director/Board Member | 47 | 19-06-06 |
Frank Oakes
BRD | Director/Board Member | 73 | 10-04-08 |
Patrick Marshall
BRD | Director/Board Member | 53 | 23-05-22 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 4.55 | +0.66% | 5,159 |
24-05-07 | 4.52 | +0.89% | 3,782 |
24-05-06 | 4.48 | -3.29% | 1,997 |
24-05-03 | 4.632 | +1.70% | 3,197 |
24-05-02 | 4.555 | +2.30% | 4,358 |
Delayed Quote Nasdaq, May 08, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.44% | 14.63M | |
+2.93% | 108B | |
+1.89% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- EDSA Stock